Point of care testing in children undergoing cardiopulmonary bypass

Pediatric Blood and Cancer

Volumn 56, Issue 5, 2011, Pages 794-798

  Tirosh Wagner, Tal ^a   Strauss, Tzipi ^a,b   Rubinshtein, Marina ^a   Tamarin, Ilia ^b   Mishaly, David ^a   Paret, Gideon ^a   Kenet, Gili ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cardiopulmonary bypass; Cone and platelet analyzer (CPA); Congenital heart disease; Pediatric; ROTEM; Thromboelastography

Indexed keywords

FIBRINOGEN;

ARTICLE; AUTOANALYZER; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD TRANSFUSION; BODY WEIGHT; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONE AND PLATELET ANALYZER; CONGENITAL HEART DISEASE; CORE TEMPERATURE; CYANOTIC HEART DISEASE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INFANT; MALE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; ROTATING THROMBOELASTOGRAM; SCHOOL CHILD; THROMBIN TIME; THROMBOELASTOGRAPHY;

BLOOD COAGULATION TESTS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; PLATELET COUNT; POINT-OF-CARE SYSTEMS; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; PROSPECTIVE STUDIES; THROMBELASTOGRAPHY;

EID: 79952141385     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22803     Document Type: Article

References (29)

1. Behrman RE, Jenson K. Nelson textbook of pediatrics. Philadelphia: W.B. Saunders 2007.
2. Moons P, Sluysmans T, De Wolf D, et al. Congenital heart disease in 111 225 births in Belgium: Birth prevalence, treatment and survival in the 21st century. Acta Paediatr 2009; 98: 472-477.
3. Parr KG, Patel MA, Dekker R, et al. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth 2003; 17: 176-181.
4. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76: 1680-1697.
5. Bick RL. Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits. Semin Thromb Hemost 1985; 11: 249-280.
6. Khuri SF, Wolfe JA, Josa M, et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992; 104: 94-107.
7. Mammen EF, Koets MH, Washington BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985; 11: 281-292.
8. Bachmann F, McKenna R, Cole ER, et al. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70: 76-85.
9. Chan AK, Leaker M, Burrows FA, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997; 77: 270-277.
10. Kern FH, Morana NJ, Sears JJ, et al. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 541-546.
11. Miller BE, Mochizuki T, Levy JH, et al. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997; 85: 1196-1202.
12. Williams GD, Bratton SL, Riley EC, et al. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1999; 13: 398-404.
13. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: A multivariate analysis in children after open-heart surgery. Anesth Analg 1999; 89: 57-64.
14. Kneyber MC, Hersi MI, Twisk JW, et al. Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med 2007; 33: 1414-1422.
15. Kovesi T, Royston D. Pharmacological approaches to reducing allogeneic blood exposure. Vox Sang 2003; 84: 2-10.
16. Anderson L, Quasim I, Soutar R, et al. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006; 16: 31-39.
17. Cammerer U, Dietrich W, Rampf T, et al. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96: 51-57, table of contents.
18. Reinhofer M, Brauer M, Franke U, et al. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008; 19: 212-219.
19. Miller BE, Guzzetta NA, Tosone SR, et al. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000; 90: 1324-1330.
20. Varon D, Dardik R, Shenkman B, et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85: 283-294.
21. Kenet G, Lubetsky A, Shenkman B, et al. Cone and platelet analyser (CPA): A new test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 1998; 101: 255-259.
22. Rossi AF, Khan DM, Hannan R, et al. Goal-directed medical therapy and point-of-care testing improve outcomes after congenital heart surgery. Intensive Care Med 2005; 31: 98-104.
23. Straub A, Schiebold D, Wendel HP, et al. Using reagent-supported thromboelastometry (ROTEM) to monitor haemostatic changes in congenital heart surgery employing deep hypothermic circulatory arrest. Eur J Cardiothorac Surg 2008; 34: 641-647.
24. Williams GD, Bratton SL, Nielsen NJ, et al. Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1998; 12: 633-638.
25. Gerrah R, Snir E, Brill A, et al. Platelet function changes as monitored by cone and plate(let) analyzer during beating heart surgery. Heart Surg Forum 2004; 7: E191-E195.
26. Ostrowsky J, Foes J, Warchol M, et al. Plateletworks platelet function test compared to the thromboelastograph for prediction of postoperative outcomes. J Extra Corpor Technol 2004; 36: 149-152.
27. Ronald A, Dunning J. Can the use of thromboelastography predict and decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg 2005; 4: 456-463.
28. Osthaus WA, Boethig D, Johanning K, et al. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis 2008; 19: 220-225.
29. Strauss T, Levy-Shraga Y, Ravid B, et al. Clot formation of neonates tested by thromboelastography correlates with gestational age. Thromb Haemost 2010; 103: 344-350.